RICCHETTI INCORPORATED for NOVARTIS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
issues related to the PDUFA reauthorization (Prescription Drug User Fee Authorization Act) issues related to drug importation (Prescription Drug Affordability Act, H.R. 194, Pharmaceutical Market Access and Safety Drug Act, S. 242, H.R. 380)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Advertising ADV
Issues relating to direct-to-consumer marketing of prescription drugs (FDA Amendments Act, HR 2900, S. 1082)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Copyright/Patent/Trademark CPT
issues related to the Patent Reform Act (S. 1145, HR 1908)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Medicare/Medicaid MMM
issues related to CHAMP (Children's Health and Medicare Protection Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBEE | N/A |
| JEFF RICCHETTI | N/A |
| STEVE RICCHETTI | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.